BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gomollón F, Calvet X. Optimising acid inhibition treatment. Drugs 2005;65 Suppl 1:25-33. [PMID: 16335855 DOI: 10.2165/00003495-200565001-00005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Nishida T, Tsujii M, Tanimura H, Tsutsui S, Tsuji S, Takeda A, Inoue A, Fukui H, Yoshio T, Kishida O, Ogawa H, Oshita M, Kobayashi I, Zushi S, Ichiba M, Uenoyama N, Yasunaga Y, Ishihara R, Yura M, Komori M, Egawa S, Iijima H, Takehara T. Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. World J Gastroenterol 2014; 20(15): 4362-4369 [PMID: 24764674 DOI: 10.3748/wjg.v20.i15.4362] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
2 Gravina AG, Priadko K, Granata L, Facchiano A, Scidà G, Cerbone R, Ciamarra P, Romano M. Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study. Front Pharmacol 2021;12:667584. [PMID: 33995097 DOI: 10.3389/fphar.2021.667584] [Reference Citation Analysis]